103 related articles for article (PubMed ID: 26994829)
21. High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson's disease cohort.
Fazio P; Ferreira D; Svenningsson P; Halldin C; Farde L; Westman E; Varrone A
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2407-2416. PubMed ID: 32020370
[TBL] [Abstract][Full Text] [Related]
22. The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites.
Zeng Z; Chen TB; Miller PJ; Dean D; Tang YS; Sur C; Williams DL
Nucl Med Biol; 2006 May; 33(4):555-63. PubMed ID: 16720249
[TBL] [Abstract][Full Text] [Related]
23. A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System.
Beliveau V; Ganz M; Feng L; Ozenne B; Højgaard L; Fisher PM; Svarer C; Greve DN; Knudsen GM
J Neurosci; 2017 Jan; 37(1):120-128. PubMed ID: 28053035
[TBL] [Abstract][Full Text] [Related]
24. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype.
Reimold M; Smolka MN; Schumann G; Zimmer A; Wrase J; Mann K; Hu XZ; Goldman D; Reischl G; Solbach C; Machulla HJ; Bares R; Heinz A
J Neural Transm (Vienna); 2007; 114(5):635-9. PubMed ID: 17225932
[TBL] [Abstract][Full Text] [Related]
25. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.
Lundberg J; Borg J; Halldin C; Farde L
Psychopharmacology (Berl); 2007 Dec; 195(3):425-33. PubMed ID: 17874074
[TBL] [Abstract][Full Text] [Related]
26. Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study.
Prieto E; Collantes M; Delgado M; Juri C; García-García L; Molinet F; Fernández-Valle ME; Pozo MA; Gago B; Martí-Climent JM; Obeso JA; Peñuelas I
Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2228-37. PubMed ID: 21874322
[TBL] [Abstract][Full Text] [Related]
27. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
28. Increased serotonin transporter availability in the brainstem of migraineurs.
Schuh-Hofer S; Richter M; Geworski L; Villringer A; Israel H; Wenzel R; Munz DL; Arnold G
J Neurol; 2007 Jun; 254(6):789-96. PubMed ID: 17351723
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
30. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
[TBL] [Abstract][Full Text] [Related]
31. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
[TBL] [Abstract][Full Text] [Related]
32. Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [
Nørgaard M; Ganz M; Svarer C; Frokjaer VG; Greve DN; Strother SC; Knudsen GM
Neuroimage; 2019 Oct; 199():466-479. PubMed ID: 31158479
[TBL] [Abstract][Full Text] [Related]
33. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.
Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C
Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865
[TBL] [Abstract][Full Text] [Related]
34. Validation of 4-[18F]-ADAM as a SERT imaging agent using micro-PET and autoradiography.
Ma KH; Huang WS; Kuo YY; Peng CJ; Liou NH; Liu RS; Hwang JJ; Liu JC; Chen HJ; Shiue CY
Neuroimage; 2009 Apr; 45(3):687-93. PubMed ID: 19211037
[TBL] [Abstract][Full Text] [Related]
35. Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.
Takano A; Varrone A; Gulyás B; Karlsson P; Tauscher J; Halldin C
Neuroimage; 2008 Aug; 42(2):474-82. PubMed ID: 18617423
[TBL] [Abstract][Full Text] [Related]
36. Individually differentiated serotonergic raphe nuclei measured with brain PET/MR imaging.
Son YD; Cho ZH; Choi EJ; Kim JH; Kim HK; Lee SY; Chi JG; Park CW; Kim JH; Kim YB
Radiology; 2014 Aug; 272(2):541-8. PubMed ID: 24654972
[TBL] [Abstract][Full Text] [Related]
37. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Suzuki K; Higuchi M; Suhara T
Int J Neuropsychopharmacol; 2009 Sep; 12(8):1021-32. PubMed ID: 19236731
[TBL] [Abstract][Full Text] [Related]
38. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
[TBL] [Abstract][Full Text] [Related]
39. A probabilistic approach to delineating functional brain regions.
Kalbitzer J; Svarer C; Frokjaer VG; Erritzoe D; Baaré WF; Madsen J; Hasselbalch SG; Knudsen GM
J Nucl Med Technol; 2009 Jun; 37(2):91-5. PubMed ID: 19447857
[TBL] [Abstract][Full Text] [Related]
40. Human 5-HT transporter availability predicts amygdala reactivity in vivo.
Rhodes RA; Murthy NV; Dresner MA; Selvaraj S; Stavrakakis N; Babar S; Cowen PJ; Grasby PM
J Neurosci; 2007 Aug; 27(34):9233-7. PubMed ID: 17715358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
